ATE286057T1 - Pharmazeutische zubereitungen enthaltend clavulansäure - Google Patents

Pharmazeutische zubereitungen enthaltend clavulansäure

Info

Publication number
ATE286057T1
ATE286057T1 AT01987751T AT01987751T ATE286057T1 AT E286057 T1 ATE286057 T1 AT E286057T1 AT 01987751 T AT01987751 T AT 01987751T AT 01987751 T AT01987751 T AT 01987751T AT E286057 T1 ATE286057 T1 AT E286057T1
Authority
AT
Austria
Prior art keywords
clavulanic acid
pharmaceutical preparations
preparations containing
containing clavulanic
mum
Prior art date
Application number
AT01987751T
Other languages
English (en)
Inventor
Stefan Horkovics-Kovats
Johannes Raneburger
Franz Xaver Schwarz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3689001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE286057(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE286057T1 publication Critical patent/ATE286057T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/10—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D503/12—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6
    • C07D503/14—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, attached in position 3
    • C07D503/16—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical
    • C07D503/18—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01987751T 2000-10-20 2001-10-18 Pharmazeutische zubereitungen enthaltend clavulansäure ATE286057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT18062000 2000-10-20
PCT/EP2001/012076 WO2002032906A1 (en) 2000-10-20 2001-10-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE286057T1 true ATE286057T1 (de) 2005-01-15

Family

ID=3689001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01987751T ATE286057T1 (de) 2000-10-20 2001-10-18 Pharmazeutische zubereitungen enthaltend clavulansäure

Country Status (13)

Country Link
US (1) US20040043981A1 (de)
EP (1) EP1328528B1 (de)
JP (2) JP2004511561A (de)
KR (1) KR20030069995A (de)
CN (1) CN1267437C (de)
AT (1) ATE286057T1 (de)
AU (1) AU2002221702A1 (de)
CA (1) CA2424462C (de)
DE (1) DE60108154T2 (de)
ES (1) ES2234919T3 (de)
MX (1) MXPA03003312A (de)
PL (1) PL360254A1 (de)
WO (1) WO2002032906A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7295509B2 (en) 2000-09-13 2007-11-13 Qualcomm, Incorporated Signaling method in an OFDM multiple access system
US9130810B2 (en) 2000-09-13 2015-09-08 Qualcomm Incorporated OFDM communications methods and apparatus
US9246560B2 (en) 2005-03-10 2016-01-26 Qualcomm Incorporated Systems and methods for beamforming and rate control in a multi-input multi-output communication systems
US9154211B2 (en) 2005-03-11 2015-10-06 Qualcomm Incorporated Systems and methods for beamforming feedback in multi antenna communication systems
US8446892B2 (en) 2005-03-16 2013-05-21 Qualcomm Incorporated Channel structures for a quasi-orthogonal multiple-access communication system
US9520972B2 (en) 2005-03-17 2016-12-13 Qualcomm Incorporated Pilot signal transmission for an orthogonal frequency division wireless communication system
US9143305B2 (en) 2005-03-17 2015-09-22 Qualcomm Incorporated Pilot signal transmission for an orthogonal frequency division wireless communication system
US9184870B2 (en) 2005-04-01 2015-11-10 Qualcomm Incorporated Systems and methods for control channel signaling
US9036538B2 (en) 2005-04-19 2015-05-19 Qualcomm Incorporated Frequency hopping design for single carrier FDMA systems
US9408220B2 (en) 2005-04-19 2016-08-02 Qualcomm Incorporated Channel quality reporting for adaptive sectorization
US8879511B2 (en) 2005-10-27 2014-11-04 Qualcomm Incorporated Assignment acknowledgement for a wireless communication system
US8462859B2 (en) 2005-06-01 2013-06-11 Qualcomm Incorporated Sphere decoding apparatus
US9179319B2 (en) 2005-06-16 2015-11-03 Qualcomm Incorporated Adaptive sectorization in cellular systems
US8599945B2 (en) 2005-06-16 2013-12-03 Qualcomm Incorporated Robust rank prediction for a MIMO system
US8885628B2 (en) 2005-08-08 2014-11-11 Qualcomm Incorporated Code division multiplexing in a single-carrier frequency division multiple access system
US9209956B2 (en) 2005-08-22 2015-12-08 Qualcomm Incorporated Segment sensitive scheduling
US8644292B2 (en) 2005-08-24 2014-02-04 Qualcomm Incorporated Varied transmission time intervals for wireless communication system
US9136974B2 (en) 2005-08-30 2015-09-15 Qualcomm Incorporated Precoding and SDMA support
US8693405B2 (en) 2005-10-27 2014-04-08 Qualcomm Incorporated SDMA resource management
US8045512B2 (en) 2005-10-27 2011-10-25 Qualcomm Incorporated Scalable frequency band operation in wireless communication systems
US9225488B2 (en) 2005-10-27 2015-12-29 Qualcomm Incorporated Shared signaling channel
US9144060B2 (en) 2005-10-27 2015-09-22 Qualcomm Incorporated Resource allocation for shared signaling channels
US8582509B2 (en) 2005-10-27 2013-11-12 Qualcomm Incorporated Scalable frequency band operation in wireless communication systems
US8477684B2 (en) 2005-10-27 2013-07-02 Qualcomm Incorporated Acknowledgement of control messages in a wireless communication system
US9225416B2 (en) 2005-10-27 2015-12-29 Qualcomm Incorporated Varied signaling channels for a reverse link in a wireless communication system
US9210651B2 (en) 2005-10-27 2015-12-08 Qualcomm Incorporated Method and apparatus for bootstraping information in a communication system
US9088384B2 (en) 2005-10-27 2015-07-21 Qualcomm Incorporated Pilot symbol transmission in wireless communication systems
AU2010242948A1 (en) * 2009-04-29 2011-11-24 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29038A (en) * 1860-07-03 George a
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
WO2000041478A2 (en) * 1999-04-01 2000-07-20 Dsm N.V. Agglomerates by crystallisation

Also Published As

Publication number Publication date
DE60108154T2 (de) 2005-12-22
AU2002221702A1 (en) 2002-04-29
DE60108154D1 (de) 2005-02-03
JP2009197020A (ja) 2009-09-03
US20040043981A1 (en) 2004-03-04
CN1469880A (zh) 2004-01-21
CN1267437C (zh) 2006-08-02
CA2424462A1 (en) 2002-04-25
EP1328528B1 (de) 2004-12-29
ES2234919T3 (es) 2005-07-01
EP1328528A1 (de) 2003-07-23
WO2002032906A1 (en) 2002-04-25
PL360254A1 (en) 2004-09-06
MXPA03003312A (es) 2004-12-03
CA2424462C (en) 2010-03-30
KR20030069995A (ko) 2003-08-27
JP2004511561A (ja) 2004-04-15

Similar Documents

Publication Publication Date Title
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
YU49698A (sh) Smeše koje sadrže tetrahidrolipstatin
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
EA200300081A1 (ru) Гидрогель-управляемая лекарственная форма
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
HUP0301349A2 (hu) IL-11-tartalmú készítmények
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
IT1301966B1 (it) Composizioni farmaceutiche ad attivita' analgesica
FR2774687B1 (fr) Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
DE60112756D1 (de) Racecadotril enthaltende trockene pulverformulierung
DE60137069D1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
SE0001916D0 (sv) Novel formulation
RS50345B (sr) Vodena farmaceutska kompozicija koja sadrži ciklesonid
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1328528

Country of ref document: EP